Alexandria Real Estate Equities (NYSE:ARE) Upgraded to Hold at Zacks Research

Zacks Research upgraded shares of Alexandria Real Estate Equities (NYSE:ARE) from a strong sell rating to a hold rating in a report released on Wednesday,Zacks.com reports.

A number of other research firms have also weighed in on ARE. BNP Paribas Exane raised their price objective on shares of Alexandria Real Estate Equities from $45.00 to $48.00 and gave the company an “underperform” rating in a research note on Wednesday, August 5th. Royal Bank Of Canada dropped their target price on shares of Alexandria Real Estate Equities from $60.00 to $50.00 and set a “sector perform” rating on the stock in a research note on Tuesday, May 5th. Mizuho reduced their price target on shares of Alexandria Real Estate Equities from $70.00 to $60.00 and set an “outperform” rating for the company in a research report on Monday, July 6th. Citizens Jmp restated a “market perform” rating on shares of Alexandria Real Estate Equities in a report on Monday. Finally, Wall Street Zen cut Alexandria Real Estate Equities from a “hold” rating to a “sell” rating in a research report on Saturday, August 8th. Two investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Reduce” and an average target price of $52.38.

Alexandria Real Estate Equities Trading Up 4.9%

NYSE ARE opened at $53.03 on Wednesday. Alexandria Real Estate Equities has a 12 month low of $39.41 and a 12 month high of $88.24. The company has a current ratio of 0.19, a quick ratio of 0.19 and a debt-to-equity ratio of 0.67. The stock’s fifty day moving average price is $50.57 and its 200-day moving average price is $49.60. The stock has a market cap of $9.24 billion, a P/E ratio of -8.75 and a beta of 1.15.

Alexandria Real Estate Equities (NYSE:ARE) last posted its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.52). The company had revenue of $662.78 million during the quarter, compared to analysts’ expectations of $464.86 million. Alexandria Real Estate Equities had a negative return on equity of 5.21% and a negative net margin of 36.08%.Alexandria Real Estate Equities’s revenue for the quarter was down 13.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.33 EPS. Alexandria Real Estate Equities has set its FY 2026 guidance at 6.350-6.450 EPS. As a group, equities analysts forecast that Alexandria Real Estate Equities will post 6.38 EPS for the current fiscal year.

Alexandria Real Estate Equities Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Tuesday, June 30th were paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 5.4%. The ex-dividend date was Tuesday, June 30th. Alexandria Real Estate Equities’s dividend payout ratio (DPR) is -47.52%.

Insiders Place Their Bets

In other Alexandria Real Estate Equities news, CFO Marc E. Binda sold 2,000 shares of the stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $54.00, for a total value of $108,000.00. Following the transaction, the chief financial officer owned 188,264 shares of the company’s stock, valued at approximately $10,166,256. This represents a 1.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Chairman Joel S. Marcus bought 5,000 shares of the company’s stock in a transaction on Monday, August 17th. The stock was purchased at an average cost of $46.28 per share, for a total transaction of $231,400.00. Following the completion of the transaction, the chairman directly owned 592,724 shares of the company’s stock, valued at approximately $27,431,266.72. The trade was a 0.85% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 1.35% of the stock is currently owned by corporate insiders.

Institutional Trading of Alexandria Real Estate Equities

Several large investors have recently added to or reduced their stakes in the business. BlackRock Inc. purchased a new stake in Alexandria Real Estate Equities during the second quarter valued at approximately $1,146,423,000. Norges Bank bought a new position in Alexandria Real Estate Equities in the fourth quarter worth approximately $805,429,000. Invesco Ltd. boosted its stake in shares of Alexandria Real Estate Equities by 57.9% during the 4th quarter. Invesco Ltd. now owns 6,033,304 shares of the real estate investment trust’s stock worth $295,270,000 after acquiring an additional 2,211,424 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Alexandria Real Estate Equities by 1,022.1% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,813,955 shares of the real estate investment trust’s stock worth $151,175,000 after acquiring an additional 1,652,298 shares during the last quarter. Finally, Bank of New York Mellon Corp bought a new stake in shares of Alexandria Real Estate Equities during the 2nd quarter valued at $79,253,000. 96.54% of the stock is currently owned by institutional investors.

About Alexandria Real Estate Equities

Alexandria Real Estate Equities, Inc (NYSE: ARE) is a real estate investment trust specializing in the ownership, development and management of collaborative life science and technology campuses. The company’s properties are designed to support research and innovation by providing specialized laboratory, office and manufacturing space tailored to biotechnology, pharmaceutical, academic and related industries.

Since its founding in 1994, Alexandria has cultivated a diversified portfolio of campuses across leading innovation clusters in North America and Europe.